AE-101

N/A

Report date: 2024/06/12 17:40:18

Base Information

Drug NameAE-101
Drug Alias NameAE-101ARVN-901DWR-2206
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsKeratitisFuchs' Endothelial Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMacauSouth Korea +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesActualEyes Inc
China Registration ClassN/A

Develop Information

Active CompaniesD Western Therapeutics Institute IncActualEyes IncArctic Vision (Hong Kong) Ltd
Inactive CompaniesN/A
Active IndicationsKeratitisFuchs' Endothelial Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A